Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer

Clinical trial NCT03829722 · COMPLETED

Trial details

NCT number: NCT03829722
Sponsor: University of Michigan Rogel Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Oropharynx Squamous Cell Carcinoma

Start date: 2019-09-05
Primary completion: 2024-06-11
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.